Importer of Controlled Substances Application: Noramco, Inc., 12408 [2018-05725]
Download as PDF
<![CDATA[
12408
Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Notices
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
17, 2017, Rhodes Technologies, 498
Washington Street, Coventry, Rhode
Island 02816 applied to be registered as
a bulk manufacturer the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
sradovich on DSK3GMQ082PROD with NOTICES
Marihuana .....................
Tetrahydrocannabinols
Dihydromorphine ..........
Methylphenidate ...........
Codeine ........................
Dihydrocodeine .............
Oxycodone ...................
Hydromorphone ............
Hydrocodone ................
Levorphanol ..................
Morphine .......................
Oripavine ......................
Thebaine .......................
Oxymorphone ...............
Noroxymorphone ..........
Tapentadol ....................
Fentanyl ........................
Drug
code
Schedule
7360
7370
9145
1724
9050
9120
9143
9150
9193
9220
9300
9330
9333
9652
9668
9780
9801
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to finished
dosage form manufacturers.
In reference to drug code 7360 and
7370, the company plans to bulk
manufacture a synthetic CBD and
tetrahydrocannabinol.
No other activity for drug code 7360
and 7370 are authorized for this
registration.
Dated: March 15, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–05745 Filed 3–20–18; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
18:34 Mar 20, 2018
Jkt 244001
DEPARTMENT OF JUSTICE
Controlled substance
Drug
code
Schedule
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Noramco, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 20, 2018. Such persons
may also file a written request for a
hearing on the application on or before
April 20, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a),
this is notice that on July 6, 2017,
Noramco, Inc., 500 Swedes Landing
Road, Wilmington, Delaware 19801–
4417 applied to be registered as an
importer of the following basic
controlled substances:
Marihuana .....................
Tetrahydrocannabinols
Nabilone .......................
Phenylacetone ..............
Opium, raw ...................
Poppy Straw Concentrate.
Tapentadol ....................
7360
7370
7379
8501
9600
9670
I
I
II
II
II
II
9780
II
DATES:
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
The company plans to import
phenylacetone (8501), opium, raw
(9600), and poppy straw concentrate
(9670) to bulk manufacture other
controlled substances for distribution to
its customers. The company plans to
import an intermediate form of
tapentadol (9780) to bulk manufacture
tapentadol (9780) for distribution to its
customers.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration. Placement of these
drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C 952(a)(2). Authorization
will not extend to the import of FDA
approved or non-approved finished
dosage forms for commercial sale.
Dated: March 15, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–05725 Filed 3–20–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Agency Information Collection
Activities; Comment Request; Senior
Community Service Employment
Program (SCSEP)
Notice of information collection;
request for comment.
ACTION:
The Department of Labor
(DOL), Employment and Training
Administration (ETA) is soliciting
comments concerning a proposed
extension for the authority to conduct
the information collection request (ICR)
titled, ‘‘Senior Community Service
Employment Program (SCSEP).’’ This
comment request is part of continuing
Departmental efforts to reduce
SUMMARY:
E:\FR\FM\21MRN1.SGM
21MRN1
]]>Agencies
[Federal Register Volume 83, Number 55 (Wednesday, March 21, 2018)]
[Notices]
[Page 12408]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05725]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Noramco, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 20, 2018. Such
persons may also file a written request for a hearing on the
application on or before April 20, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is
notice that on July 6, 2017, Noramco, Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801-4417 applied to be registered as an importer
of the following basic controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Nabilone............................... 7379 II
Phenylacetone.......................... 8501 II
Opium, raw............................. 9600 II
Poppy Straw Concentrate................ 9670 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to import phenylacetone (8501), opium, raw
(9600), and poppy straw concentrate (9670) to bulk manufacture other
controlled substances for distribution to its customers. The company
plans to import an intermediate form of tapentadol (9780) to bulk
manufacture tapentadol (9780) for distribution to its customers.
In reference to drug codes 7360 and 7370, the company plans to
import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No
other activity for these drug codes is authorized for this
registration. Placement of these drug codes onto the company's
registration does not translate into automatic approval of subsequent
permit applications to import controlled substances. Approval of permit
applications will occur only when the registrant's business activity is
consistent with what is authorized under 21 U.S.C 952(a)(2).
Authorization will not extend to the import of FDA approved or non-
approved finished dosage forms for commercial sale.
Dated: March 15, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-05725 Filed 3-20-18; 8:45 am]
BILLING CODE 4410-09-P
